Cutting-edge basic and translational cardiovascular research: that’s Frontiers in CardioVascular Biomedicine (FCVB) 2022, a scientific congress of the European Society of Cardiology (ESC). The ...
DURHAM, N.C., July 19, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissues, today ...
The American Heart Association’s (AHA) Council on Basic Cardiovascular Sciences has selected Juhyun Lee, assistant professor in the Bioengineering Department at The University of Texas at Arlington, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback